Skip to main content
ORTHOCELL LIMITED logo

ORTHOCELL LIMITED — Investor Relations & Filings

Ticker · OCC ISIN · AU000000OCC6 ASX Manufacturing
Filings indexed 780 across all filing types
Latest filing 2026-05-13 Share Issue/Capital Cha…
Country AU Australia
Listing ASX OCC

About ORTHOCELL LIMITED

https://orthocell.com/

Orthocell Limited is a regenerative medicine company focused on the development and commercialization of innovative technologies for the repair and regeneration of human soft tissue. The company’s core product portfolio includes the CelGro platform, a naturally derived collagen medical device designed to facilitate tissue repair and reconstruction in applications such as dental bone and soft tissue regeneration, nerve repair, and tendon repair. Orthocell also specializes in advanced cellular therapies, notably Ortho-ATI (Autologous Tenocyte Implantation) for treating chronic tendon injuries and Ortho-ACI (Autologous Chondrocyte Implantation) for cartilage repair. These therapies utilize a patient's own cells to restore function and structure to damaged tissues. The company aims to provide restorative solutions that improve clinical outcomes and offer alternatives to traditional surgical interventions.

Recent filings

Filing Released Lang Actions
Application for quotation of securities - OCC 8 pages 20.7KB
Share Issue/Capital Change Classification · 92% confidence The document is the ASX Listing Rule Appendix 2A “Application for quotation of securities,” detailing the issue and quotation of 500,000 new shares following option conversions. This is a regulatory announcement of a new share issue/capital change rather than a financial report or mere publication notice. It fits the “Share Issue/Capital Change” category.
2026-05-13 English
Cleansing Notice 2 pages 597.8KB
Share Issue/Capital Change Classification · 92% confidence The document is an ASX announcement notifying the market under section 708A of the Corporations Act that the Company has issued 500,000 new fully paid ordinary shares following option exercise. This is a routine announcement of a new share issue (capital change), matching the definition of Share Issue/Capital Change (SHA).
2026-05-13 English
Application for quotation of securities - OCC 8 pages 21.5KB
Regulatory Filings
2026-05-04 English
Cleansing Notice 2 pages 597.7KB
Regulatory Filings
2026-05-04 English
Appendix 3Y - John Van Der Wielen 2 pages 220.0KB
Regulatory Filings
2026-05-03 English
Appendix 3Y - Michael McNulty 2 pages 219.8KB
Regulatory Filings
2026-05-03 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.